BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15753237)

  • 1. The lifetime risk of suicide in schizophrenia: a reexamination.
    Palmer BA; Pankratz VS; Bostwick JM
    Arch Gen Psychiatry; 2005 Mar; 62(3):247-53. PubMed ID: 15753237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicide risk in schizophrenia: learning from the past to change the future.
    Pompili M; Amador XF; Girardi P; Harkavy-Friedman J; Harrow M; Kaplan K; Krausz M; Lester D; Meltzer HY; Modestin J; Montross LP; Mortensen PB; Munk-Jørgensen P; Nielsen J; Nordentoft M; Saarinen PI; Zisook S; Wilson ST; Tatarelli R
    Ann Gen Psychiatry; 2007 Mar; 6():10. PubMed ID: 17367524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and schizophrenia: is there a paradox?
    Hodgson R; Wildgust HJ; Bushe CJ
    J Psychopharmacol; 2010 Nov; 24(4 Suppl):51-60. PubMed ID: 20923920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
    Saha S; Chant D; McGrath J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1123-31. PubMed ID: 17909124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia and suicide: systematic review of risk factors.
    Hawton K; Sutton L; Haw C; Sinclair J; Deeks JJ
    Br J Psychiatry; 2005 Jul; 187():9-20. PubMed ID: 15994566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia: a concise overview of incidence, prevalence, and mortality.
    McGrath J; Saha S; Chant D; Welham J
    Epidemiol Rev; 2008; 30():67-76. PubMed ID: 18480098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature Mortality Among Adults With Schizophrenia in the United States.
    Olfson M; Gerhard T; Huang C; Crystal S; Stroup TS
    JAMA Psychiatry; 2015 Dec; 72(12):1172-81. PubMed ID: 26509694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide and schizophrenia: a systematic review of rates and risk factors.
    Hor K; Taylor M
    J Psychopharmacol; 2010 Nov; 24(4 Suppl):81-90. PubMed ID: 20923923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the prevalence of schizophrenia.
    Saha S; Chant D; Welham J; McGrath J
    PLoS Med; 2005 May; 2(5):e141. PubMed ID: 15916472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
    N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide as an outcome for mental disorders. A meta-analysis.
    Harris EC; Barraclough B
    Br J Psychiatry; 1997 Mar; 170():205-28. PubMed ID: 9229027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine use in children and adolescents.
    Gogtay N; Rapoport J
    Expert Opin Pharmacother; 2008 Feb; 9(3):459-65. PubMed ID: 18220495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess early mortality in schizophrenia.
    Laursen TM; Nordentoft M; Mortensen PB
    Annu Rev Clin Psychol; 2014; 10():425-48. PubMed ID: 24313570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia.
    van Os J; Kapur S
    Lancet; 2009 Aug; 374(9690):635-45. PubMed ID: 19700006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute risk of suicide after first hospital contact in mental disorder.
    Nordentoft M; Mortensen PB; Pedersen CB
    Arch Gen Psychiatry; 2011 Oct; 68(10):1058-64. PubMed ID: 21969462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The positive and negative syndrome scale (PANSS) for schizophrenia.
    Kay SR; Fiszbein A; Opler LA
    Schizophr Bull; 1987; 13(2):261-76. PubMed ID: 3616518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.
    Hjorthøj C; Stürup AE; McGrath JJ; Nordentoft M
    Lancet Psychiatry; 2017 Apr; 4(4):295-301. PubMed ID: 28237639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis.
    Penttilä M; Jääskeläinen E; Hirvonen N; Isohanni M; Miettunen J
    Br J Psychiatry; 2014 Aug; 205(2):88-94. PubMed ID: 25252316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of atypical antipsychotics : differential risk and clinical implications.
    Haddad PM; Sharma SG
    CNS Drugs; 2007; 21(11):911-36. PubMed ID: 17927296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.